Primary prevention of cardiovascular disease: time to get more or less personal?
Hingorani
Aroon D
AD
Genetic Epidemiology Group, Department of Epidemiology and Public Health and the Centre for Clinical Pharmacology, University College London, London, England, UK. a.hingorani@ucl.ac.uk
Psaty
Bruce M
BM
D002318:Cardiovascular Diseases / Q000517:prevention & control*; D057186:Comparative Effectiveness Research; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D057285:Precision Medicine; D011322:Primary Prevention; D018570:Risk Assessment
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors